MedTrace Logo

Assessment of Global Myocardial Perfusion Reserve Using Coronary Sinus Flow Measurements

NCT02697877 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 183

Last updated 2019-10-24

No results posted yet for this study

Summary

The aim of this study is to assess whether myocardial perfusion reserve, measured during routine clinically ordered regadenoson stress cardiac magnetic resonance (CMR) has prognostic value in predicting adverse cardiovascular events. Myocardial perfusion reserve will be measured with CMR by assessing blood flow through the coronary-sinus - the primary vein in the heart.

Conditions

Interventions

DRUG

Regadenoson

Sponsors & Collaborators

  • Astellas Pharma Inc

    collaborator INDUSTRY

  • University of Illinois at Chicago

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2018-02-28
Completion
2018-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02697877 on ClinicalTrials.gov